基质血管部分
去细胞化
干细胞
间质细胞
生物医学工程
再生(生物学)
脂肪组织
间充质干细胞
组织工程
再生医学
细胞生物学
解剖
化学
病理
医学
生物
生物化学
作者
Ethan L. Nyberg,Ashley L. Farris,Aine N. O'Sullivan,Ricardo Luis Rodriguez,Warren L. Grayson
出处
期刊:Tissue Engineering Part A
[Mary Ann Liebert]
日期:2019-11-01
卷期号:25 (21-22): 1459-1469
被引量:31
标识
DOI:10.1089/ten.tea.2018.0341
摘要
Large craniofacial bone defects remain a clinical challenge due to their complex shapes and large volumes. Stem cell-based technologies that deliver osteogenic stem cells have shown remarkable regenerative potential but are hampered by the need for extensive in vitro manipulation before implantation. To address this, we explored the bone forming potential of the clinically relevant stromal vascular fraction (SVF) cells obtained from human lipoaspirate. SVF cells can be isolated for acute use in the operating room and contain a subpopulation of adipose-derived stromal/stem cells (ASCs) that can develop mineralized tissue. ASCs can be purified from the more heterogeneous population of SVF cells via secondary and tertiary culture on tissue culture plastic. In this study, the relative potential for using SVF cells or passaged ASCs to induce robust bone regeneration was compared. Isogenic SVF and ASCs were suspended in fibrin hydrogels and seeded in three-dimensional-printed osteoinductive scaffolds of decellularized bone matrix and polycaprolactone. In vitro, both cell populations successfully mineralized the scaffold, demonstrating the robust bone formation properties of SVF. In murine critical-sized cranial defects, ASC-loaded scaffolds had greater (but not statistically significant) bone volume and bone coverage area than SVF-loaded scaffolds. However, both cell-laden interventions resulted in significantly greater bone healing than contralateral acellular controls. In conclusion, we observed substantial in vitro mineralization and robust in vivo bone regeneration in tissue-engineered bone grafts using both SVF and passaged ASCs. Impact Statement The inability to effectively regenerate bone within critical-sized craniofacial defects is a present clinical challenge and overcoming this limitation using tissue engineering strategies would significantly advance current treatment outcomes. The present study tests the feasibility of harvesting stem cells intraoperatively, combining them with three-dimensional (3D)-printed osteoinductive scaffolds and, without culturing in vitro, implanting them into the bone defect to stimulate regeneration. The data from this study demonstrated that SVF isolated from lipoaspirate and used in vivo with minimal processing could be combined with a 3D-printed bioactive material in a point-of-care approach to promote bone regeneration.
科研通智能强力驱动
Strongly Powered by AbleSci AI